Jennifer Sherak

Jennifer Sherak is a seasoned executive in the oncology and pharmaceutical sectors, currently serving on the Board of Directors at LiveWorld since January 2024. Previously, Jennifer held significant leadership roles, including SVP & President of Specialty Physician Services at AmerisourceBergen from April 2021 to May 2023 and Global Head of Oncology New Products at Takeda Oncology from January 2018 to April 2021. Additional experience includes positions at Shire, Baxalta, and Sigma-Tau Pharmaceuticals, where Jennifer contributed to oncology product strategy and marketing. Jennifer's early career included roles at Celgene, Bristol-Myers Squibb, and Novartis, focusing on oncology marketing and sales training. Jennifer earned an MBA from William & Mary and a BA in Chemistry from East Carolina University.